Market niche opportunity Small specialty compounding pharmacy focusing on custom sublingual immunotherapy and oral mucosal immunotherapy presents a target for growth through expanded patient access programs, partnerships with allergy clinics, and direct-to-consumer education initiatives to raise awareness of functional allergy treatment options.

Growth potential Revenue is under one million with a lean team, indicating opportunity for scalable sales through channel partnerships, co-marketing with allergy specialists, and expansion into adjacent markets such as chronic sinusitis and asthma management therapies.

Digital outreach Existing tech stack and online presence (WordPress, social channels, contact forms) can be leveraged to drive patient inquiries and physician referrals; consider targeted digital campaigns and content focused on immunotherapy benefits and at-home treatment convenience.

Strategic partnerships Size and scope align with potential collaborations with mid-sized allergy networks or clinics seeking specialized immunotherapy compounding; propose reseller or white-label arrangements, training support, and ongoing product development collaborations.

Competitive landscape With peers ranging from small nonprofits to multi-hundreds-employee firms, there is room to differentiate through personalized formulations, rapid fulfillment, and emphasis on preventive health benefits to capture a share of allergy patient journeys.